e-learning
resources
Courses
2017
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Translational therapeutics in pleural malignancies
F. Rodriguez Panadero (Tomares (Sevilla), Spain)
Source:
ERS Skills course - Medical thoracoscopy
Number:
13
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
F. Rodriguez Panadero (Tomares (Sevilla), Spain). Translational therapeutics in pleural malignancies. ERS Skills course - Medical thoracoscopy
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Asbestosis
Management of solitary fibrous tumours of the pleura: a systematic review and meta-analysis
Diagnosis and staging of malignant pleural mesothelioma
Related content which might interest you:
Rational approaches to pleural malignancies
Source: International Congress 2018 – State of the art session: Thoracic oncology
Year: 2018
Novel therapeutic strategies against malignant pleural mesothelioma by selumetinib-loaded targeted nanoparticles.
Source: International Congress 2017 – Mesothelioma and malignant pleural disease
Year: 2017
Advances in pleural infection and malignancy
Source: Eur Respir Rev, 30 (159) 200002; 10.1183/16000617.0002-2020
Year: 2021
Multimodality therapy for malignant pleural mesothelioma
Source: Eur Respir J 2004; 24: Suppl. 48, 526s
Year: 2004
Malignant mesothelioma: new treatment advances, including targeted therapies
Source: Virtual Congress 2021 – Diagnostic and therapeutic advances in mesothelioma care
Year: 2021
Biological markers of successful pleurodesis for malignant pleural effusion
Source: International Congress 2016 – Mesothelioma and pleural disease: from the bench to the bedside
Year: 2016
Multimodal management of malignant pleural mesothelioma: where are we today?
Source: Eur Respir J 2014; 44: 754-764
Year: 2014
Pleural effusion in lung cancer and targeted therapy
Source: Hands-on Course 2013 - Medical Thoracoscopy
Year: 2013
ERS/ESTS/EACTS/ESTRO guidelines for the management of malignant pleural mesothelioma
Source: Eur Respir J, 55 (6) 1900953; 10.1183/13993003.00953-2019
Year: 2020
Advances in pleural disease
Source: Eur Respir Rev 2016; 25: 108-109
Year: 2016
Immunotherapy for malignant pleural mesothelioma: ready for clinical practice?
Source: International Congress 2016 – Immunotherapy: the lethal weapon against thoracic malignancies?
Year: 2016
Programme PD7 Designing and conducting research in malignant pleural effusion
Source: International Congress 2016 – PD7 Designing and conducting research in malignant pleural effusion
Year: 2016
Malignant pleural mesothelioma: new treatments, new hopes?
Source: Eur Respir J , 49 (3) 1700319; DOI: 10.1183/13993003.00319-2017
Year: 2017
The utility of survivin mRNA as a diagnostic biomarker in lung cancer with malignant pleural effusion
Source: Annual Congress 2013 –Fundamental biology of malignant pleural effusions
Year: 2013
Immunology-based therapeutic strategies in lung cancer and mesothelioma
Source: International Congress 2014 – Beyond tyrosine kinase inhibition: promising new developments in molecular oncology
Year: 2014
Role of tumor derived versican in experimental malignant pleural mesothelioma
Source: International Congress 2016 – Mesothelioma and pleural disease: from the bench to the bedside
Year: 2016
Detection of EpCAM-positive microparticles in pleural fluid: A new approach for the diagnosis of the tumoral origin of pleural effusions
Source: International Congress 2015 – Emerging technologies for malignant pleural diseases management
Year: 2015
Update on biology and management of mesothelioma
Source: Eur Respir Rev, 30 (159) 200226; 10.1183/16000617.0226-2020
Year: 2021
Intrapleural photodynamic therapy for malignant pleural mesothelioma: A new dosimetry approach
Source: International Congress 2016 – Mesothelioma and malignant pleural disease
Year: 2016
Management of malignant pleural effusion in recurrent SCLC by intrapleural gene therapy
Source: Eur Respir J 2003; 22: Suppl. 45, 61s
Year: 2003
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept